Ranitidine Alternatives

Ranitidine Alternatives is a pharmacotherapeutic strategy comprising histamine-2 receptor antagonists or proton pump inhibitors that serve as substitutes for ranitidine in the management of peptic ulcer disease, distinguished by their equivalent or superior efficacy, safety, and risk-benefit profile following ranitidine's market withdrawal.

7

Publications

132

Citations

29

Authors

17

Institutions

Publications per year

2017–2026

0

Authors

29

  1. BP
    Bonnie Pobiner

    GlaxoSmithKline (United States), United States

    1 publications · 26 citations

    1

    h-index

  2. SL
    Stig Larsen

    Norwegian University of Life Sciences, Norway

    1 publications · 32 citations

    1

    h-index

  3. JO
    J Oleksy

    Krakow Cardiovascular Research Institute, Poland

    1 publications · 11 citations

    1

    h-index

  4. JF
    Jonathan Filinto

    Pfizer (United States), United States

    1 publications · 16 citations

    1

    h-index

  5. MO
    M. Osnes

    Oslo University Hospital, Norway

    1 publications · 32 citations

    1

    h-index

1–5 of 29

Venues

  1. 1

    h-index

  2. The American Journal of Medicine

    1 publications · 16 citations

    1

    h-index

  3. Digestive Diseases and Sciences

    1 publications · 16 citations

    1

    h-index

  4. PharmacoEconomics

    1 publications · 20 citations

    1

    h-index

  5. PubMed

    Repository · 1 publications · 11 citations

    1

    h-index

1–5